Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERIBULIN vs ERLOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERIBULIN vs ERLOTINIB: Safety Overview

Metric ERIBULIN ERLOTINIB
Total FAERS Reports 5,055 22,472
Deaths Reported 793 6,791
Death Rate 15.7% 30.2%
Hospitalizations 2,642 3,693
Average Patient Age 57.3 yrs 67.2 yrs
% Female Patients 93.0% 59.8%
FDA Approval Date Apr 5, 2024 Apr 16, 2020
Manufacturer Gland Pharma Limited Zydus Lifesciences Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued